Accessibility Menu
Exosens logo

Exosens(ENXT) EXENS

Market Cap€2.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€58.05
-1.11%
-0.65Today

Exosens Financials at a Glance

Market Cap

€2.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€928.51M

Net Income (TTM)

€113.34M

EPS (TTM)

€1.05

P/E Ratio

56.02

Dividend

€0.30

Beta (Volatility)

-0.06 (Low)

Price

€58.05

Volume

91,061

Open

€59.15

Previous Close

€58.05

Daily Range

€57.95 - €59.15

52-Week Range

€36.20 - €74.00

Estimated Earnings Date

Jul 28, 2026

EXENS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Exosens

Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. The company offers a diverse range of products and services, catering to various sectors including defense, industrial research, and environmental monitoring.

Products and Services
  • Image intensifier tubes and advanced camera systems
  • Detection products including gamma and neutron detectors
  • Power tubes and airborne solutions for methane detection
Growth Outlook
  • Revenue increased to EUR 253.1 million in Q2 2026
  • Net income reached EUR 15.3 million in the latest quarter
  • Strong demand across multiple international markets supports expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of EUR 1.01 billion
  • Operating income margin at 12.4% for Q2 2026
  • Current ratio of 2.35 indicates strong liquidity position
Exosens has established itself as a leader in the electro-optical technology sector, with a robust product portfolio that addresses critical needs in various industries. The recent quarterly performance reflects a solid upward trend in revenue and profitability, showcasing the company's ability to capitalize on market opportunities. The strong liquidity position, indicated by a current ratio of 2.35, further enhances the company's financial stability. With a focus on innovation and expansion into new markets, Exosens is well-positioned for continued growth in the coming years.
AI Generated • Aug 11, 2026

Industry

Aerospace and Defense

Employees

1,573

CEO

Jérôme Cerisier, MBA

Headquarters

Mérignac, NA 33700, FR

EXENS Financials

Key Financial Metrics (TTM)

Gross Margin

17.43%

Operating Margin

17.96%

Net Income Margin

11.59%

Return on Equity

12.85%

Return on Capital

14.08%

Return on Assets

6.43%

Earnings Yield

1.79%

Dividend Yield

0.51%

Payout Ratio

26.43%

Stock Overview

Market Cap

€2.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

50.91M

Volume

91.06K

Avg. Volume

86.04K

Financials (TTM)

Gross Profit

€272.71M

Operating Income

€185.13M

EBITDA

€264.98M

Operating Cash Flow

€209.96M

Capital Expenditure

-€105.60M

Free Cash Flow

€104.36M

Cash & ST Invst.

€105.20M

Total Debt

€269.50M

Exosens Performance Analysis

Exosens annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 200,752,00020.8%
20232023-12-31EUR 291,819,00045.4%
20242024-12-31EUR 383,441,00031.4%
20252025-12-31EUR 468,187,00022.1%
Exosens sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3110.9%
Q22025-06-308.3%
Q42025-12-318.5%
Q22026-06-303.9%
Exosens annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.02N/A
20232023-12-31EUR 0.14816.5%
20242024-12-31EUR 0.61322.9%
20252025-12-31EUR 1.30111.8%
Exosens sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-311544.4%
Q22025-06-30-15.4%
Q42025-12-31-47.3%
Q22026-06-303.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€253.10M

+35.4%

Gross Profit

€32.70M

-81.7%

Gross Margin

12.92%

N/A

Market Cap

€2.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.49M

N/A

Employees

2,000

N/A

Net Income

€15.30M

+2528.6%

EBITDA

€77.60M

+92.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€105.20M

-14.7%

Total Debt

€269.50M

+3.7%

Accounts Receivable

€76.40M

+4.8%

Inventory

€123.30M

+29.9%

Long Term Debt

€264.20M

+3.0%

Short Term Debt

€5.30M

+60.8%

Return on Assets

6.43%

N/A

Return on Invested Capital

11.67%

N/A

Free Cash Flow

€25.60M

+94.2%

Operating Cash Flow

€58.10M

+160.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EXENS

What is the current price of Exosens?

Exosens is trading at €58.05 per share.

What is the 52-week range for Exosens?

Over the past 52 weeks, Exosens has traded between €36.20 and €74.00.

How much debt does Exosens have?

As of the most recent reporting period, Exosens reported total debt of €266.35M.

How much cash does Exosens have on hand?

Exosens reported €68.62M in cash and cash equivalents in its most recent financial results.

What is Exosens’s dividend yield?

Exosens currently has a dividend yield of 0.51%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.